Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.
Alkermes seeks a Territory Business Manager for the Richmond area to drive sales of Alkermes products and support promotional efforts for sleep-disorder therapies. You will educate healthcare providers, build target lists, and develop business plans in collaboration with the Regional Business Director.
Travel up to 80% may be required; strong selling skills and disease knowledge are essential. We offer a base salary of $150,000–$185,000 with a performance bonus of up to $50,000 and long-term
In February 2026, Alkermes completed the acquisition of Avadel Pharmaceuticals plc. This acquisition added an approved product in the sleep medicine market. Territory Business Manager (TBM) will report directly to the Regional Business Director (RBD). Will be responsible for selling Alkermes products in the Richmond territory and supporting promotional efforts on our products approved to treat certain sleep disorders. Ideal candidates should be proven sales achievers and live in the territory. This will be done by having thorough product, disease state and market knowledge and sound selling skills. He/she will utilize available resources to help educate healthcare providers. Finally, he/she will use their analytical ability to determine appropriate targets and will use approved resources accordingly.
ESSENTIAL AREAS OF RESPONSIBILITY:
The annual base salary for this position ranges from $150,000 to $185,000. In addition, this position offers a performance based sales incentive bonus targeted at fifty thousand dollars annually and eligibility to participate in our long term incentive program. Exact compensation may vary based on skills, training, knowledge, and experience. Alkermes offers a competitive benefits package. Additional details can be found on our careers website: www.alkermes.com/careers#working-here
Alkermes applies its decades of deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders. A global biopharmaceutical company, headquartered in Ireland with U.S. locations in Massachusetts and Ohio, we seek to make a meaningful difference in the way people manage their diseases. We have a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia, bipolar I disorder and narcolepsy, and a pipeline of clinical and preclinical candidates in development for various psychiatric and neurological disorders.
We are proud to have been recognized as an employer of choice by many national organizations. In 2024 and 2025, we were certified as a Great Place to Work in the U.S. and named one of Massachusetts’ Top Places to Work by the Boston Globe, a Best Place to Work in Greater Cincinnati by the Cincinnati Business Courier and recognized as a Best Place to Work in BioPharma by Fortune Magazine.
Alkermes, Inc. is an equal employment opportunity employer and does not discriminate against any qualified applicant or employee because of race, creed, color, age, national origin, ancestry, religion, gender, sexual orientation, gender expression and identity, disability, genetic information, veteran status, military status, application for military service or any other characteristic protected by local, state or federal law. Alkermes also complies with all work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Alkermes is an E-Verify employer.